Editas Medicine, Inc.
EDIT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $40.5M | $32.3M | +25.4% |
| Operating income | −$160M | −$251M | +36.3% |
| Net income | −$160M | −$237M | +32.5% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $10.4M | $7.50M | +38.7% |
| Operating income | −$24.3M | −$24.5M | +0.8% |
| Net income | −$23.4M | −$25.1M | +6.8% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Editas Medicine's revenue in FY2025?
- $40.5M in FY2025 (Fiscal year ended Dec 31, 2025), +25.4% vs $32.3M a year earlier, per its 10-K filed Mar 2026.
- Was Editas Medicine profitable in FY2025?
- No: net income was −$160M and operating income −$160M in FY2025.
- What was Editas Medicine's revenue in Q3 2026?
- $10.4M (+38.7% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.